Stay updated on PXL770 Efficacy in NAFLD: 12-Week Clinical Trial
Sign up to get notified when there's something new on the PXL770 Efficacy in NAFLD: 12-Week Clinical Trial page.

Latest updates to the PXL770 Efficacy in NAFLD: 12-Week Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedA new revision label 'Revision: v3.3.3' is now shown. References to 'HHS Vulnerability Disclosure' and the prior 'Revision: v3.3.2' have been removed.SummaryDifference0.2%

- Check17 days agoNo Change Detected
- Check24 days agoNo Change Detected
- Check38 days agoChange DetectedThe version history now lists revision v3.3.2 and removes v3.2.0 from the records.SummaryDifference0.1%

- Check45 days agoChange DetectedThe government funding/operating status banner that previously appeared on the page has been removed.SummaryDifference0.8%

- Check59 days agoChange DetectedThe screenshots show only minor visual/layout adjustments on the Record History page with no changes to core content or historical data; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check88 days agoChange DetectedUpdate includes a critical operating-status notice and an upgraded version identifier to v3.2.0, replacing the previous v3.1.0.SummaryDifference12%

- Check95 days agoChange DetectedChanged the revision from v3.0.2 to v3.1.0, indicating a minor version update with no other content changes.SummaryDifference0.3%

Stay in the know with updates to PXL770 Efficacy in NAFLD: 12-Week Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PXL770 Efficacy in NAFLD: 12-Week Clinical Trial page.